References in periodicals archive ?
However, IO was considered too difficult for most adult patients until the mid-2000s, when Vidacare Corporation pioneered the EZ-IO Intraosseous Infusion System, now widely considered the leading technology to establish IO for all patients in need of intraosseous access.
SAN ANTONIO -- Vidacare Corporation announced today that the EZ-IO[R] Intraosseous Infusion System has sold its one millionth needle set, marking a major growth milestone for the company.
Intraosseous infusion is a technique for accessing the central circulation through blood vessels within the bone marrow that are held open by a rigid, non-collapsible bony wall.
Philip Faris, chief executive officer of Vidacare Corporation, the developer and manufacturer of the EZ-IO(R), a major innovation in intraosseous infusion technology, said that "The recommendations made by ILCOR, the American Heart Association, and the European Resuscitation Council all reasonably lead to the conclusion that IO has a vital role in emergency care.
Since acquiring their innovative intraosseous technology from the University of Texas, Vidacare has orchestrated an exceptional effort to bring intraosseous infusion to the medical community to provide safe, fast and secure access in emergency medical situations and during routine clinical care.
SAN ANTONIO -- The American Heart Association recently announced revised guidelines for Advanced Cardiac Life Support (ACLS)(1) that now recommend intraosseous infusion (IO) as the first alternative to IV in cardiac arrest patients.
She and some of the expatriate doctors wanted to increase the care they offered to include intravenous (IV) therapy, nasal gastric fluids and intraosseous infusions for children.
Intraosseous infusions were also excluded from the study, as only advanced life support providers in the study setting had this scope of practice.